Yin-Yang of EP receptor expression

Journal of Leukocyte Biology

Volumn 92, Issue 6, 2012, Pages 1129-1131

  Steinke, John W ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

COX; Fc RI; NSAID; PGE2

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; CYCLIC AMP; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FCEPSILON RECEPTOR I; IMMUNOGLOBULIN RECEPTOR; LYMPHOCYTE ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 3; TRANSCRIPTION FACTOR YY1; UNCLASSIFIED DRUG; CYCLIC AMP DEPENDENT PROTEIN KINASE; IMMUNOGLOBULIN E;

ASPIRIN EXACERBATED RESPIRATORY DISEASE; CALCIUM TRANSPORT; CYTOKINE PRODUCTION; EDITORIAL; INFLAMMATORY DISEASE; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; T LYMPHOCYTE ACTIVATION; ANIMAL; DEGRANULATION; FEMALE; HUMAN; IMMUNOLOGY; METABOLISM; NOTE; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEGRANULATION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; HUMANS; IMMUNOGLOBULIN E; MAST CELLS; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE; SIGNAL TRANSDUCTION;

EID: 84870466572     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0812374     Document Type: Editorial

References (10)

1. Kay, L. J., Yeo, W. W., Peachell, P. T. (2006) Prostaglandin E2 activated EP2 receptors to inhibit human lung mast degranulation. Br. J. Pharmacol. 147, 707-713.
2. Feng, C., Beller, E. M., Bagga, S., Boyce, J. A. (2006) Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses. Blood 107, 3243-3250.
3. Nguyen, M., Solle, M., Audoly, L. P., Tilley, S. L., Stock, J. L., McNeish, J. D., Coffman, T. M., Dombrowicz, D., Koller, B. H. (2002) Receptors and signaling mechanisms required for prostaglandin E2-mediated regulation of mast cell degranulation and IL-6 production. J. Immunol. 169, 4586-4593.
4. Serra-Pages, M., Olivera, A., Torres, R., Picado, C., de Mora, F., Rivera, J. (2012) E-prostanoid 2 receptors dampen mast cell degranulation via cAMP/PKA-mediated suppression of IgE-dependent signaling. J. Leukoc Biol. 92, 1155-1165.
5. Steinke, J. W., Payne, S. C., Borish, L. (2012) Interleukin-4 in the generation of the AERD phenotype: implications for molecular mechanisms driving therapeutic benefit of aspirin desensitization. J. Allergy (Cairo) 2012, 182090.
6. Sladek, K., Szczeklik, A. (1993) Cysteinyl leukotrienes overproduction and mast cell activation in aspirn-provoked bronchospasm in asthma. Eur. Respir. J. 6, 391-399.
7. Perez-Novo, C. A., Watelet, J. B., Claeys, C., van Cauwenberge, P., Bachert, C. (2005) Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J. Allergy Clin. Immunol. 115, 1189-1196.
8. Picado, C., Fernandez-Morata, J. C., Juan, M., Roca-Ferrer, J., Fuentes, M., Xaubet, A., Mullol, J. (1999) Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirinsensitive asthmatics. Am. J. Respir. Crit. Care Med. 160, 291-296.
9. Ying, S., Meng, Q., Scadding, G., Parikh, A., Corrigan, C. J., Lee, T. H. (2006) Aspirinsensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells. J. Allergy Clin. Immunol. 117, 312-318.
10. Sestini, P., Armetti, L., Gambaro, G., Pieroni, M. G., Refini, R. M., Sala, A., Vaghi, A., Folco, G. C., Bianco, S., Robuschi, M. (1996) Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am. J. Respir. Crit. Care Med. 153, 572-575.